IL6 and neoplasm: The role of CHD1L has been thoroughly described in cancer literature to drive tumour proliferation lead to poor cancer prognosis [41–43] possibly by regulating immune factors in regulating apoptosis such as CD8+ T-cell populations and IL-6 levels [44].